| Name | Title | Contact Details |
|---|
ThromboGenics is an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic and oncology medicines. The Company`s lead product, JETREA® (ocriplasmin), has been approved by the US FDA for the treatment of symptomatic VMA and was launched in January 2013. ThromboGenics signed a strategic partnership with Alcon, a division of Novartis, for the commercialization of JETREA® outside the United States. ThromboGenics is headquartered in Leuven, Belgium, and has offices in Iselin, NJ (US) and Dublin, Ireland. The Company is listed on the NYSE Euronext Brussels exchange under the symbol THR.
BioScrip is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avanti Therapeutics is a Clarksburg, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Advanced Targeting Systems is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Moderna COVID-19 Vaccine Clinic and Health Fair Let’s do our part! Corktown Health is offering the Moderna COVID-19 vaccine on 5/21, 5/28, 6/1, 6/4, and 6/5 from 8:30am to 1pm. We will also be offering vaccines at the Hazel Park Recreation Center on 6/...